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Edited by Giulio Superti-FurgaAbstract TRAF6 is an E3 ubiquitin ligase that transduces sig-
nals from members of the TLR/IL-1R family. Multiple mole-
cules have been found to associate with TRAF6 and exert their
functions in this pathway. Herein, by yeast two-hybrid screen
using TRAF6 as bait, we identiﬁed PP4 as a potential
TRAF6-interacting protein. PP4 physically interacted with
TRAF6 and was recruited to TLR4 complex upon LPS stimula-
tion. PP4 negatively regulated LPS-induced and TRAF6-medi-
ated NF-jB activation by inhibiting the ubiquitination of
TRAF6. LPS stimulation also induced the expression of PP4.
Taken together, our ﬁndings suggest that PP4 is a negative feed-
back regulator of LPS/TLR4 pathway.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The innate immune response in vertebrates is the ﬁrst line of
defense against infectious pathogens. In innate immune sys-
tem, diﬀerent phagocytes such as neutrophils, macrophages,
and dendritic cells play crucial roles in discriminating between
pathogens and self by utilizing signals from the toll-like recep-
tors (TLRs) [1,2]. LPS serves as a ligand speciﬁc for TLR4.
Ligation of LPS to TLR4 leads to signal activation via down-Abbreviations: TRAF6, tumor necrosis factor receptor-associated
factor 6; TLR, toll-like receptor; IL, interleukin; NF-jB, nuclear fac-
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kinase; JNK, c-Jun N-terminal kinase; MyD88, myeloid diﬀerentiation
primary response gene 88; IRAK, IL-1 receptor-associated kinase;
TAK1, transforming growth factor-b-activated kinase-1; TOLLIP,
toll-interacting protein; SOCS, suppressor of cytokine signaling; IKK,
IjB kinase; TNF, tumor necrosis factor; TAB, TAK1 binding protein;
CSF, colony-stimulating factor; CYLD, cylindromatosis; TCR, T-cell
receptor
q This work was supported by grants from the National Natural
Science foundation of China (30271454 and 30571743) and the High
Tech Research and Development (863) Programme of China
(2007AA02Z156).
*Corresponding authors. Fax: +86-27-6875-4131 (Y. Qi).
E-mail address: qiyipeng@whu.edu.cn (Y. Qi).
1Both authors contributed equally to this work.
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.07.014stream signaling factors, which includes the adaptors MyD88,
IRAKs, TRAF6 and TAK1, and thereafter induce the nuclear
transport of NF-jB and the activation of a set of MAPKs
[2,3]. TRAF6 is essential for the signal activation, as TRAF6
deﬁciency results in defective LPS signaling [4]. Similar to most
TRAF proteins, TRAF6 is composed of a highly conserved
TRAF-C domain, a TRAF-N domain and a more variable
amino-terminal domain that contains a RING-ﬁnger and sev-
eral Zn ﬁngers [5]. TRAF6 has been demonstrated to be a
RING-ﬁnger-dependent E3 ubiquitin ligase which is itself acti-
vated by ubiquitination through a K63-ubiquitinated mecha-
nism [6,7].
The activation of TLRs can eﬀectively protect the host, but
sustained activation may lead to the development of chronic
inﬂammatory disorders. To prevent detrimental and overactive
inﬂammatory responses, TLR signaling must be tightly con-
trolled. So far, the uncovered negative regulation underlying
the TLRs signaling can be divided into ﬁve levels [8]. Recent
studies by us and others have identiﬁed many intracellular
inhibitors that negative regulates TLRs pathways, such as
TOLLIP, MyD88s, IRAK-M, SOCS1, SOCS3, CYLD and
A20 [8–10]. Among these regulators, SOCS1, A20 and CYLD
have been demonstrated to inhibit the activation of TRAF6.
Protein phosphatase 4 is a protein serine/threonine phospha-
tase belonging to the PP2A phosphatase family. PP4 is highly
conserved during evolution, suggesting that PP4, like PP1 and
PP2A (the most conserved enzymes known in eukaryote evolu-
tion), might serve critical functions in vivo [11]. Previous stud-
ies have shown that PP4 involves in multiple cellular processes,
including regulation of microtubule growth/organization,
apoptosis, TNF-a signaling, thymocyte development, pre-T-
cell receptor signaling, and the activation of JNK and NF-
jB [12–16]. Herein, by yeast two-hybrid screening, we found
PP4 physically associated with an important signal transducer
TRAF6, and acted as a negative regulator in TRAF6- and
LPS-mediated NF-jB activation through its inhibition on
the ubiquitination of TRAF6. Together, all these data have de-
ﬁned a novel role of PP4 in the innate immune system.2. Materials and methods
2.1. Antibodies and reagents
Anti-TLR4, anti-TRAF6, anti-FLAG, anti-HA, horseradish perox-
idase-conjugated anti-mouse and anti-rabbit IgG antibodies and LPS
were described previously [17]. Anti-Ub was purchased from Santa
Cruz Biotechnology. Anti-PPP4C was purchased from ptglab.
Anti-b-actin was from Abcam.blished by Elsevier B.V. All rights reserved.
Fig. 1. Interaction of PP4 and TRAF6. (A) Interaction between PP4
and TRAF6 proteins in yeast. (B) TRAF6 interacts with PP4 in an
over-expressed system in HEK293T cells. (C) A schematic presentation
of TRAF6, its deletion mutants, and the interaction with wild-type
PP4. (D) The TRAF-C domain of TRAF6 is required for its
interaction with PP4.
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PP4 cDNA was ampliﬁed by PCR, then cloned into pCMV-Tag2
(Stratagene), pGBKT7 and pGADT7 (Clontech) vectors, respectively.
Murine TRAF6 was cloned into pGBKT7, pGADT7 and pCMV-HA
(Clontech). The TRAF6 mutants were ampliﬁed by PCR.
2.3. Yeast two-hybrid system
Yeast two-hybrid screens were performed using the Matchmaker
GAL4 Two Hybrid System 3 (Clontech) and the human fetal brain
Matchmaker cDNA library (Clontech) following the manufacturers
instructions. The same system was used for detecting the interaction
of two proteins following the manufacturers instructions.
2.4. Cell culturing, transient transfection, and treatment
The murine RAW264.7 cells were grown, stimulated and transfected
as described before [17]. HEK293T cells were cultured in DMEM (Hy-
clone) supplemented with 10% heat-inactivated fetal bovine serum,
100 U/ml penicillin and 100 U/ml streptomycin. Transfections were
carried out using Lipofectin 2000 (Invitrogen) according to the manu-
facturers instructions.
2.5. NF-jB assay
Cells were transfected with 100 ng of the pNF-jB luciferase reporter
(Stratagene) and 10 ng of the pRL-TK Renilla reporter (Promega), in
combination with the indicated expression plasmids. Cells were
harvested after the indicated periods of time, and the ﬁreﬂy luciferase
levels were determined using the Dual-Luciferase Reporter Assay
System (Promega). The level of Renilla luciferase activity was used
to normalize the transfection eﬃciencies. The luciferase assay was done
in triplicate, and the results are shown as means ± standard errors
(S.E.).
2.6. RNA isolation and RT-PCR
Total cellular RNAs were extracted using the TRIzol reagent
(Invitrogen) according to the manufacturers protocol. The cDNA
was reverse transcribed from 1.0 lg total RNA with oligo dT using
the M-MLV Reverse Transcriptase (Promega) as recommended by
the supplier. Subsequently, the cDNA preparations were used as the
templates for PCR to amplify GAPDH and PP4.
2.7. Immunoblotting and immunoprecipitation
Cells were lysed with MPER Protein Extraction Reagent (Pierce),
and equal amounts of the samples were loaded for SDS–PAGE.
Immunoblotting was carried out on nitrocellulose membranes (Phar-
marcia) and the samples were detected using an ECL reagent (Pierce).
Immunoprecipitation was carried out using a MPER Immunoprecipi-
tation Kit (Pierce).
2.8. RNA interference
The RNAi pSilencer system (Ambion) was used. The diﬀerent pSi-
lencer recombinant vectors were constructed by inserting 64-mer syn-
thetic DNA oligonucleotides that encode two 19-nucleotide (nt)
reverse complements with homology to a portion of the target gene.
For the mPP4 siRNA construct, target sequence was nt 91–109. For
the EGFP siRNA construct, the target sequence was nt 158–176.3. Results
3.1. Interaction ofPP4 with TRAF6
In an attempt to identify novel proteins involved in TRAF6-
related signaling pathway, we performed yeast two-hybrid
screens with full length murine TRAF6 as bait and a human
fetal brain cDNA library as target. By screening and b-galac-
tosidase assays we obtained a cDNA encoding a 151-amino
acid protein identical to the C-terminus (the 157–307 amino
acids) of PP4. To further conﬁrm whether the full-length
PP4 could also interact with TRAF6, we constructed various
GAL4 DNA-binding domain (BD) and GAL4 transcriptionactivation domain (AD) fusion proteins as shown in Fig. 1A.
Both BD-TRAF6/AD-PP4 and BD-PP4/AD-TRAF6 express-
ing AH109 transformants turned out to be positive in b-galac-
tosidase assays, and we concluded that PP4 might be a
potential TRAF6-binding protein.
In an eﬀort to verify their interactions in vivo, we performed
immunoprecipitation under over-expression conditions in
HEK293T cells and found that FLAG-PP4 could co-precipi-
tate with HA-TRAF6 (Fig. 1B). The results indicated that
PP4 interacted with TRAF6 when over-expressed in cells.
TRAF6 is a multifunction protein with several domains. The
RING-ﬁnger and zinc ﬁnger domains can mediate downstream
signaling events and the TRAF-C domain is for protein–pro-
tein interaction [5]. To determine which domain of TRAF6
interacts with PP4, we constructed some truncated mutant
forms of TRAF6 (Fig. 1C), and detected whether these mutant
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tion assays. Results shown in Fig. 1D suggested that the
TRAF-C domain of TRAF6 was suﬃcient for its interaction
with PP4.
3.2. PP4 is recruited to TLR4 complex upon LPS stimulation in
RAW264.7 cells
As TRAF6 has been proved to be a pivotal signal transducer
in LPS/TLR4 pathway, it is quickly recruited to the TLR4
complex upon LPS stimulation, then leading to the activation
of NF-jB. To determine whether the endogenous PP4 is asso-
ciated with TRAF6 and recruited into TLR4 complex, we per-
formed endogenous co-immunoprecipitation experiments in
RAW264.7 cells stimulated with or without LPS. As shown
in Fig. 2A, PP4 was not associated with TRAF6 in unstimu-
lated RAW264.7 cells, but their interaction emerged when
the cells were treated with LPS. LPS treatment also induced
the recruitment of PP4 into TLR4 receptor complex (Fig.
2B), suggesting that endogenous PP4 was recruited into
TLR4 receptor complex in a LPS-stimulated manner.
3.3. PP4 inhibits LPS-induced and TRAF6-mediated NF-jB
activation
The above data that PP4 could bind to TRAF6 in response
to LPS ligation suggests that PP4 may be involved inFig. 2. PP4 is recruited to the TLR4 signaling complex after LPS
stimulation. Wild-type RAW264.7 cells were unstimulated () or
stimulated (+) with LPS (500 ng/ml). Cell lysates were immunoprecip-
itates (IP) with anti-TRAF6 (A), anti-TLR4 (B) or control antibody
and immunoblotted with anti-PP4 antibody. Cell lysates were also
probed with anti-TRAF6 (A), anti-TLR4 (B) or anti-PP4 antibody to
analyze the protein expression.LPS/TLR4 signaling cascade. To determine whether PP4 has
regulatory function in LPS- and TRAF6-mediated NF-jB
activation, we performed NF-jB luciferase reporter assays.
As shown in Fig. 3A and B, these data indicated that PP4 sup-
pressed LPS- and TRAF6-mediated NF-jB activation in a
dose-dependent manner.
To further address the functional role of PP4 in the TLR4
signaling pathway, we used siRNA to knockdown the endog-
enous expression of PP4 in RAW264.7 cells. Western blot
analysis indicated that the RNAi plasmid could inhibit the
expression of endogenous PP4 in RAW264.7 cells, while the
control RNAi plasmid had no eﬀect on PP4 expression (Fig.
3C, left panel). The expression of FLAG-PP4 could also be
knocked-down by pSilencer-PP4 (Fig. 3C, right panel). In re-
porter gene assays, PP4 knockdown by pSilencer-PP4 en-
hanced NF-jB activation by LPS or TRAF6 (Fig. 3D and
E). All these data suggested that PP4 was a negative regulator
for LPS/TLR4 signaling.3.4. PP4 exerts the negative role through suppressing the
ubiquitination of TRAF6
It has recently been demonstrated that TRAF6 is an E3
ubiquitin ligase that is ubiquitinated by itself in response to
LPS stimulation, and recycled via deubiquitination [11,18].
This polyubiquitination does not target proteins for degrada-
tion, but has been found to regulate DNA repair and protein
kinase activation through a degradation-independent mecha-
nism [19]. From the results above, we wondered the mecha-
nism underlying the negative regulation of PP4 and whether
PP4 can aﬀect the auto-ubiquitination of TRAF6. We trans-
fected RAW264.7 cells with expression plasmids for TRAF6,
PP4 and PP4-RNAi as indicated in Fig. 4A. The results indi-
cated that PP4 inhibits the ubiquitination of TRAF6.
To evaluate the eﬀect of PP4 on endogenous TRAF6, we de-
tected the ubiquitination of TRAF6 in wild-type RAW264.7
cells, PP4-introduced RAW264.7 cells and PP4 knocked-down
RAW264.7 cells in response to LPS stimulation at indicated
time. The results showed that in existence of PP4, the ubiquiti-
nating levels of TRAF6 had been obviously reduced while with
the absence of PP4, the ubiquitination of TRAF6 had been
strengthened (Fig. 4B). These results did provide supportive
envidence for our model that PP4 inhibited TRAF6-dependent
activation of NF-jB likely by inhibiting the ubiquitination of
TRAF6.3.5. PP4 exerts negative regulation in a feedback loop in
responding to LPS stimulation
Many genes involved in inﬂammatory response undergo
changes in expression pattern after various stimuli. PP2A,
another important phosphatase in PP2A family, can be in-
duced by CSF in macrophages [20]. So we hypothesized that
activation of TLR4 signaling by LPS induces PP4, which in
turns leads to the inhibition of NF-jB. We stimulated wild-
type RAW264.7 cells with LPS in diﬀerent times and found
that PP4 expression was apparently induced after 60 min
stimulation and decreased to normal at 300 min after treat-
ment (Fig. 5A). Consistent with the up-regulation in protein
level, induction of PP4 by LPS was also observed by RT-
PCR at the mRNA level (Fig. 5B). These results suggested
that PP4 was a part of the negative feedback loop of
TLR4 pathway.
Fig. 3. Expression of PP4 reduces LPS- and TRAF6-dependent NF-jB activation. (A) PP4 inhibits LPS-induced NF-jB activation in a dose-
dependent manner in RAW264.7 cells. RAW264.7 cells were transfected with expression plasmids for PP4 together with 100 ng of NF-jB luciferase
and 10 ng of pRL-TK Renilla reporter plasmids. At 36 h post-transfection, the cells were treated with LPS (500 ng/ml) for 4 h, and then the cell
lysates were collected and luciferase reporter assays were carried out. Cell lysates were also probed with anti-FLAG and anti-b-actin. (B) PP4 inhibits
TRAF6-induced NF-jB activation in a dose-dependent manner in RAW264.7 cells. RAW264.7 cells were transfected with reporter plasmids and
protein-encoding plasmids as indicated. Luciferase assays were carried out 36 h after transfection. Cell lysates were also probed with anti-FLAG and
anti-b-actin. (C) PP4 knockdown by pSilencer-PP4 markedly reduced both endogenous (left) and exogenous (right) expression of PP4. (D) Wild-type
and pSilencer-PP4 transfected RAW264.7 cells were stimulated with LPS (500 ng/ml) for 4 h or left untreated. Luciferase assays were carried out. (E)
RAW264.7 cells were transfected with TRAF6 encoding or control plasmid together with or without pSilencer-PP4. Thirty-six hours after
transfection, luciferase assays were carried out.
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the TLR4 signaling complex is in a time-dependent manner,
we stimulated RAW264.7 cells with LPS and used anti-PP4
antibody to precipitate the PP4 signaling complex. Endoge-
nous TLR4 in the precipitated signaling complex was immuno-
blotted with anti-TLR4 antibody, and its amount peaked at
90 min after stimulation, and declined thereafter to the lowest
point after 180 min. We also detected the TRAF6 in PP4 pre-
cipitation complex, their interactions appeared at 60 min after
treatment and sustained until 180 min (Fig. 5C). Time kinetics
revealed that the recruitment of PP4 to the receptor complex
did not happen immediately after stimulation, but in a PP4-
expression and LPS-stimulation dependent manner, suggestingthat PP4 was a negative regulator in a feedback loop in LPS/
TLR4 pathway.4. Discussion
In this study, we have identiﬁed PP4 as a negative regulator
of LPS/TLR4 signaling cascade that directly targets TRAF6
and suppresses its ubiquitination. Previous studies have re-
vealed that TRAF6 is a critical modulator in LPS/IL-1,
CD40, TCR and p75 pathways [4,5,21]. In an attempt to
screen TRAF6 binding proteins, PP4 was identiﬁed as a
Fig. 4. PP4 inhibits the ubiquitination of TRAF6. (A) PP4 suppresses
the ubiquitination of TRAF6. RAW264.7 cells were transfected with
plasmids as indicated. Whole cell extracts were immunoprecipitated
with anti-HA or control IgG, and immunoblotted with anti-Ub
antibody. Whole cell lysates were also probed with anti-HA or anti-
PP4 to analyze the expression of HA-TRAF6 or PP4. (B) Knockdown
of PP4 enhances the ubiquitination level of TRAF6 in RAW264.7
cells. Wild-type, pCMV-Tag2-PP4 and pSilencer-PP4 transfected
RAW264.7 cells were treated with LPS (500 ng/ml) for the indicated
times. Cell lysates were immunoprecipitated with anti-TRAF6 or
control IgG. Immunoprecipitates were immunoblotted with anti-Ub in
order to detect ubiquitinated TRAF6 or anti-TRAF6 to detect
TRAF6. Whole cell lysates were probed with anti-PP4 to analyze the
protein level of PP4.
Fig. 5. PP4 exerts negative regulation in a feedback loop in responding
to LPS stimulation. (A) LPS induces PP4 expression at the protein
level in RAW264.7 cells. Wild-type RAW264.7 cells were treated with
LPS (500 ng/ml) for the indicated times. Whole cell extracts were
collected and probed with anti-PP4 antibody to analyze the protein
level of PP4. (B) LPS induces PP4 expression at mRNA level in
RAW264.7 cells. Wild-type RAW264.7 cells were treated with LPS
(500 ng/ml) for 4 h. Total RNA was isolated and RT-PCR was carried
out. The RT-PCR products of PP4 were detected by agarose gel
electrophoresis. GAPDH was used as a control. Quantiﬁcation of PP4
mRNA was measured by gel analysis software, normalized by
calculating the ratio of the mRNA to GAPDH. (C) PP4 is recruited
to TLR4 complex at 1 h after LPS treatment. RAW264.7 cells were
stimulated with LPS (500 ng/ml) for the indicated times. Cell lysates
were immunoprecipitated with anti-PP4 or control IgG antibody, and
immunoblotted with anti-TLR4 or anti-TRAF6 antibody. Cell lysates
were also probed with anti-TLR4, anti-TRAF6, anti-PP4 or anti-b-
actin antibody.
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main of TRAF6. The suppressive role of PP4 in LPS-induced
NF-jB activation and the direct association with TRAF6 lead
us to suppose that PP4 may be an inhibitor regulating the acti-
vation of TRAF6 and LPS cascade. As TRAF6 is activated by
K63-linked ubiquitination, it can also be inactivated by
deubiquitination. By ubiquitnation assays, we found that
PP4 acts as a negative regulator in ubiquitination of TRAF6
induced by LPS. Previous studies have identiﬁed A20 and
CYLD, two deubiquinylating enzymes that accomplish their
roles by directly removing ubiquitin moieties from TRAF6
[22,23]. We carried out in vitro deubiquitination assays, but
failed to detect any deubiquinylating activity of PP4, revealing
that PP4 acts through a distinctive mechanism. Our ﬁndings
show that PP4 is also a LPS-inducible protein, because PP4
protein and its transcripts were increased after LPS stimula-tion. With the up-regulation of expression, PP4 is recruited
into the receptor complex and interact with TRAF6, suggest-
ing that PP4 is in the feedback loop of LPS/TLR4 pathway.
Protein phosphatases that catalyze the dephosphorylation of
serine and threonine residues have been classiﬁed into four
subtypes: PP1, PP2A, PP2B and PP2C. PP4 belongs to the
2848 L. Chen et al. / FEBS Letters 582 (2008) 2843–2849PP2A family which comprises of a subset of PP2A-like phos-
phatase that includes PP2A, PP4, PP5 and PP6. PP2A has
been veriﬁed to inhibit the activation of NF-jB and PP6 is in-
volved in negatively regulating the activity of TAK1 [24,25].
Recently, a large scale mapping of human protein–protein
interactions has shown that regulatory A subunit and the cat-
alytic subunit of PP2A can bind to TRAF6 [26], suggesting
that PP2A may be involved in TRAF6-associated signaling
transduction. In our experiments, we failed to detect any inter-
action between TAK1 and PP4 or IKKb and PP4, moreover,
TAK1- and IKKb-induced NF-jB were not suppressed by
co-expressed PP4, which lead us to suppose that PP4 could
not inactivate TAK1 and IKKb as PP6 or PP2A does. Previ-
ous studies on PP4 have deﬁned that PP4 is a positive regulator
that activates NF-jB and JNK [14,16]. As to the diﬀerent
observations obtained by us and others, we attribute them to
the controversy roles of PP4 in distinct pathways and cell
types. Whether PP4 acts as a phosphatase in this pathway
and which protein serves as the substrate for PP4 need to be
further elucidated. However, our ﬁndings may provide some
new insights into PP4 activities in the innate immune system.
Till now, no PP4-deﬁcient mice were obtained because the
ablation of PP4 leads to the embryonic lethality. It reveals
the importance of PP4 in mammalian development and sur-
vival, meanwhile makes it more diﬃcult to fully understand
what PP4 exactly does in diﬀerent cells.
The rapid response of TLRs to pathogen is essential for
maintaining a healthy microenvironment, but the stepped-up
inﬂammatory response is harmful to health in an uncontrolled
state. Recently, a panel of negative regulators has been identi-
ﬁed and a picture of how the immune balance in the mamma-
lian host is achieved in TLR-mediated signal transduction is
beginning to emerge. Interestingly, many of the negative regu-
lators act to block the activation of IRAK-1 and TRAF6,
which are considered as two pivotal adaptors that provide
platforms for diﬀerent signals to converge. It is of great impor-
tance to ﬁgure out how the proteins cooperate with each other
and through which mechanism they are controlled. The precise
negative regulations of TLR pathways utilizing by diﬀerent cell
types remain unknown, therefore any progress made in future
will help us understand the immune regulation in human body
better.
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